Puma Biotechnology board panel approves inducement RSU awards
Puma Biotechnology’s Compensation Committee approved inducement restricted stock unit awards covering 33,550 shares to five new non-executive employees, under Nasdaq Listing Rule 5635(c)(4), dated Sept. 1, 2026.
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on September 1, 2026, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted stock unit awards covering 33,550 shares of Puma common stock to five new non-executive empl…